Is Tetrahydrobiopterin a Therapeutic Option in Diabetic Hypertensive Patients?

Integrated Blood Pressure Control - New Zealand
doi 10.2147/ibpc.s7479
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Alpha Lipoic Acid Combined With Epalrestat: A Therapeutic Option for Patients With Diabetic Peripheral Neuropathy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Hemorrhoids: Which Is the Best Therapeutic Option?

International Surgery Journal
2018English

Is Tocilizumab a Potential Therapeutic Option for Refractory Unicentric Castleman Disease?

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Is Vitamin D a New Therapeutic Option in Coronary Artery Disease? Overview Data

Cardiovascular Pharmacology: Open Access
2015English

Hydrogen Sulfide: A Therapeutic Option in Systemic Sclerosis

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Gemcitabine Re-Challenge in Metastatic Soft Tissue Sarcomas: A Therapeutic Option for Selected Patients

Anticancer Research
MedicineCancer ResearchOncology
2018English

Lipoprotein Apheresis Is an Optimal Therapeutic Option to Reduce Increased Lp(a) Levels

Clinical Research in Cardiology Supplements
Nuclear MedicineRadiologyMolecular BiologyStructural BiologyImagingMedicine
2019English

Is Loop Ileostomy in Patients With Cecal Bascule a Viable Option?

Case Reports in Surgery
2019English

Antihypertensive Therapy for the Prevention of Nephropathy in Diabetic Hypertensive Patients

Journal of Clinical Pharmacy and Therapeutics
Pharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy